CIK 0001211583
- Non-accelerated filer
- Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 919-636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,550,718
- in 5 filings, $1.4M under 10b5-1 plans
Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 70,844 | ||
| 2026-10-12 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +2,224 | $5.53 | $12K | 69,685 |
| 2026-09-30 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 67,461 | ||
| 2026-08-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 66,302 | ||
| 2026-07-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 65,143 | ||
| 2026-06-30 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 63,984 | ||
| 2026-05-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award | +1,159 | 62,825 | ||
| 2026-04-30 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +1,159 | 61,666 | ||
| 2026-03-31 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +16,695 | 45,405 | ||
| 2026-03-31 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +1,159 | 46,564 | ||
| 2026-03-31 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +200,000 | $5.77 | $1.2M | 725,000 |
| 2026-03-28 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +13,943 | 60,507 | ||
| 2026-02-18 | Hackman Jeffrey S. Chief Executive Officer | Option exercise | +13,710 | 28,710 | ||
| 2025-05-19 | Hackman Jeffrey S. Chief Executive Officer | Purchase | +13,965 | $6.99 | $98K | 15,000 |
| 2025-05-16 | Hackman Jeffrey S. Chief Executive Officer | Purchase | +1,035 | $6.75 | $7K | 1,035 |
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Restricted Share Unit | +75,000 | 475,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +50,000 | 525,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Restricted Share Unit | +75,000 | 75,000 | ||
| 2025-03-28 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +50,000 | 450,000 | ||
| 2024-08-15 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +400,000 | $5.58 | $2.2M | 400,000 |
Page 1 of 1 · 20 trades